Open AccessTreatment outcome of multidrug-resistant tuberculosis with modified DOTS-plus strategy: A 2 years' experience
Author(s) -
Abhijeet Singh,
Rajendra Prasad,
Ramesh Kumar Kushwaha,
Rajendra K. Srivastava,
Belur Hosmane Giridhar,
Viswesvaran Balasubramanian,
Amita Jain
Publication year - 2019
Publication title -
lung india
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 25
eISSN - 0974-598X
pISSN - 0970-2113
DOI - 10.4103/lungindia.lungindia_475_18
Subject(s) - medicine , culture conversion , sputum , tuberculosis , regimen , multi drug resistant tuberculosis , directly observed therapy , adverse effect , sputum culture , mycobacterium tuberculosis , short course , cohort , surgery , intensive care medicine , pediatrics , pathology
Multidrug-resistant tuberculosis (MDR-TB) is a global health problem with notoriously difficult and challenging treatment. This study determined treatment outcome in patients of MDR-TB with modified DOTS-Plus strategy.